Dermal Fillers-Increasing Demand for Cosmetic Surgeries Accelerate the Growth of the Market

The dermal fillers market is estimated to register a CAGR of 15.38% during the forecast period of 2023 to 2032.

MRFR recognizes the following companies as the key players in the global dermal fillers market— AbbVie Inc (US), Dr. Korman Laboratories (Israel), Teoxane laboratories (Switzerland), SciVision Biotech Inc (Taiwan), Bridgepoint Group PLC (England), GALDERMA LABORATORIES, L.P (Switzerland), Merz Pharma (Germany), Sinclair Pharma (UK), Suneva Medical (US), and Medytox (South Korea).

Analyst Comment:

The report predicts that the Asia-Pacific dermal filler market will grow at the fastest rate during the forecast period due to the rising demand for cosmetic procedures in nations like South Korea, Japan, China, and India. The report goes on to say that in order to improve their market positions, the major players in the sector are concentrating on collaborations, investments, product launches, mergers and acquisitions, and strategic alliances.

Market Highlights

The global dermal fillers market is accounted to register a CAGR of 15.38% during the forecast period and is estimated to reach USD 22.58 billion by 2032.

An increasing trend of plastic surgeons performing aesthetic non-surgical procedures has been observed in the past few years. Developed countries have more advanced knowledge and uptake about the newer products and technologies, in comparison to other underdeveloped regions. For instance, with 30.4% of all non-surgical procedures and 15.5% of all surgical procedures, the USA performed the most procedures globally (24.1% of the total), followed by Brazil (8.9%) and Japan (5.7%). According to estimates, Brazil, and the United States each have more than 30% of all plastic surgeons worldwide. China, Japan, and South Korea are the next three Asian nations, respectively.

Furthermore, in Columbia, 87% of the plastic surgeons performed procedures involving the use of hyaluronic acid fillers. Such numbers elucidate an impression that the rising preference towards dermal fillers and the use of other aesthetic procedures will contribute heavily to the growth of the dermal fillers market during the assessment period.

The growing demand for facial aesthetics globally, the increasing number of aesthetic procedures performed by plastic surgeons, and cost-effective alternatives to cosmetic surgeries are propelling market growth. However, side effects associated with dermal fillers, and the black market of dermal fillers are expected to hamper the growth of the global market. Nevertheless, the increasing number of clinical trial studies and the rising demand for minimally invasive procedures are projected to create lucrative opportunities for market players.

Segment Analysis

The global dermal fillers market has been segmented based on type, application, and end user.

On the basis of type, the market is segmented into hyaluronic acid, calcium hydroxylapatite, poly-l-lactic acid, and others. The hyaluronic acid segment was attributed to holding the largest market share of over 81.50% in 2022 revenue as estimated by MRFR analysts. This is due to the growing demand for anti-aging solutions and increasing minimally invasive aesthetic treatments.

Further, we estimate that the market segment would continue to pool in the largest chunk of revenue during the forecast period. It has been identified that the segment market yet witnesses continuous innovations and movements in terms of new product launches.

On the basis of the application, the market is segmented into facial line correction, facelift, lip enhancement, and others. The facial line correction segment is projected to have the largest market share during the forecast period. This is due to low recovery time and increasing demand for non-invasive alternative solutions for treating various types of wrinkles.

On the basis of the end user, the market is segmented into specialty & dermatology clinics, hospitals, and others. The specialty & dermatology clinics segment is projected to have the largest market share during the forecast period. This is due to the increasing number of dermatology clinics, and the growing number of dermatological consultations.

Browse In-depth Market Details [Table of Content, List of Figures, List of Tables] of Dermal Fillers Market Research Report

Regional Analysis

The global dermal fillers market, based on region, has been divided into North America, Europe, Asia-Pacific, and the Rest of the World. North America consists of the US and Canada. The Europe dermal fillers market comprises Germany, France, the UK, Italy, Spain, and the rest of Europe. The dermal fillers market in Asia-Pacific has been segmented into China, India, Japan, Australia, South Korea, and the rest of Asia-Pacific. The Rest of the world’s dermal fillers market comprises of Middle East, Africa, and Latin America.

the increasing awareness about procedures related to dermal fillers, facial injectables, and beauty-related products in the US prompts are expected to foster North America’s market growth. Moreover, increasing product launches are expected to support market growth.

Moreover, the Europe market has been persistently growing owing to increasing acceptance of new aesthetic products, growing government support for the use of minimally invasive dermal procedures, and an increase in the number of product approvals and availability of products across the region.

Additionally, market factors, such as the increasing demand for facial aesthetics products, and increased awareness about non-invasive cosmetic procedures available in the market are driving the region’s growth.

Furthermore, the rest of the world's patient portal market is divided into the Middle East, Africa, and Latin America. The major factors driving the growth of the dermal fillers market in the region are the expanding distribution channels or launching a product in an untapped market, and the rising prevalence of minimally invasive procedures.

Key Findings of the Study

• The global dermal fillers market is expected to reach USD 22.58 billion by 2032, at a CAGR of 15.38% during the forecast period.


• The Asia-Pacific region accounted for the fastest-growing global market, owing to the rising per capita disposable income, and increasing demand for facial aesthetics products in the Asia-Pacific region.


• Based on type, the hyaluronic acid segment was attributed to holding the largest market in 2022, with an approximate market share of around 72.52%.


• AbbVie Inc (US), Dr. Korman Laboratories (Israel), Teoxane laboratories (Switzerland), SciVision Biotech Inc (Taiwan), Bridgepoint Group PLC (England), GALDERMA LABORATORIES, L.P (Switzerland), Merz Pharma (Germany), Sinclair Pharma (UK), Suneva Medical (US), and Medytox (South Korea) are the key market players.